Skip to main content

Hudson Bay Capital Management LP

Position in ARGX — Argenx SE

CIK 1393825 STAMFORD, CT

Position in ARGX

as of Mar 31, 2026 · filed May 13, 2026
Position Value
$21,907,500
+$3,556,290 QoQ
Shares Held
30,000
+37.5% QoQ
Ownership
0.048%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2023
10 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in ARGX Over Time

Shares Held

Position Value (USD)

Derivatives in ARGX

reported options exposure · as of Jun 30, 2024
CallValue
$0
CallShares
0
PutValue
$21,502,000
PutShares
50,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Hudson Bay Capital Management LP holds $536,414,605 across 150 Biotechnology names. ARGX ranks #6 (4.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
6 ARGX
Argenx SE
This page
30,000 $21,907,500

All Filings in ARGX

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $21,907,500 30,000
2025-12-31 $18,351,210 21,822
2025-09-30 $7,744,380 10,500
2025-06-30 $37,440,516 67,923
2024-06-30 $6,450,600 15,000
2024-06-30 $21,502,000 50,000
2024-03-31 $5,581,768 14,177
2023-12-31 $37,663,711 99,003
2023-09-30 $33,432,314 68,003
2023-06-30 $14,395,067 36,936
2023-03-31 $15,376,749 41,271